Expression of ILT2, which binds to human leukocyte antigen (HLA)-G, on NK cells and invariant NK T cells contributes to tumor tolerance by reducing the proliferative and cytotoxic activities of these cells17–20. The gene discussed is HLA-G; the disease is neoplasm.